Xenoguard
Pericardium membrane for soft tissue reconstruction
debridement prior to implantation,
measures to control the infection must
be taken, e.g. suitable drainage, negative
pressure therapy and antimicrobial
therapy. (The presence of a significant
bacterial load could compromise the
function of the surgical membrane.)
Adverse reactions
The following adverse reactions can
occur in implantation procedures of
acellular matrixes: infections, haematoma
and seroma formation, recurring tissue
damage, fistula formation, inflammation,
adhesion formation.
Potential complications
Given that Xenoguard is possibly used
in surgical wounds, the sterility of which
is not guaranteed, antimicrobial agents
are often used to help prevent infectious
complications. The use of these agents
may slow or inhibit wound healing.
In patients in critical condition or with
a severely contaminated abdomen,
complications such as delayed wound
infection, recurrence of the rupture and
the need to reoperate must be expected.
Storage
- Xenoguard is a sterile medical product
which must be stored in a clean and dry
location at room temperature away from
direct heat and sunlight.
- Store in the original packaging.
- Do not use this product after its expiry
date.
Sterilisation
This product was sterilised with ETO and
must not be resterilised. The sterility is
only guaranteed provided the packaging
is intact.
Recommendations for preparing
Xenoguard for surgical use
Note: These recommendations merely
serve as a general guideline. They do
not take precedence over institutional
protocols or professional medical
judgement on patient care. Physicians
must be familiar with the surgical
methods and techniques for biological
surgical matrixes before using Xenoguard.
Materials required
- Sterile forceps
GB